Summary & Overview
Endocrine Disorders with MCC: Inpatient Reimbursement Overview
DRG 643 addresses inpatient admissions for endocrine, nutritional, and metabolic disorders with a Major Complication or Comorbidity, capturing cases with higher clinical severity. Correct assignment impacts Medicare inpatient reimbursement because the Diagnosis-Related Group reflects greater resource needs and yields higher payment relative to less complex endocrine groups.
DRG 643 Overview
DRG 643 covers inpatient admissions for primary endocrine, nutritional, and metabolic disorders accompanied by a Major Complication or Comorbidity. Typical clinical presentations include severe endocrine crises, complicated diabetes with systemic effects, or significant metabolic derangements requiring intensive inpatient management. This Diagnosis-Related Group matters for Medicare payment because cases assigned here generally reflect higher resource use and trigger higher inpatient reimbursement relative to less complex endocrine Diagnosis-Related Groups. Accurate coding of diagnoses and documented severity directly influences assignment to this Diagnosis-Related Group and associated payment levels.